RXRX Insider Trading

Insider Ownership Percentage: 22.25%
Insider Buying (Last 12 Months): $4,440,853.30
Insider Selling (Last 12 Months): $7,260,607.96

Recursion Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Recursion Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Recursion Pharmaceuticals Share Price & Price History

Current Price: $6.98
Price Change: Price Decrease of -0.45 (-6.06%)
As of 03/22/2023 01:00 AM ET

This chart shows the closing price history over time for RXRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Recursion Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/8/2023Christopher GibsonCEOSell70,890$8.10$574,209.00963,787View SEC Filing Icon  
3/7/2023Blake BorgesonDirectorSell8,885$8.33$74,012.057,585,172View SEC Filing Icon  
3/2/2023Christopher GibsonCEOSell18,500$7.92$146,520.00940,927View SEC Filing Icon  
2/27/2023Mubadala Investment Co PjscMajor ShareholderBuy52,500$7.69$403,725.0012,869,423View SEC Filing Icon  
2/23/2023Mubadala Investment Co PjscMajor ShareholderBuy51,864$7.79$404,020.5612,707,805View SEC Filing Icon  
2/23/2023Tina Marriott LarsonCOOSell8,000$7.82$62,560.00427,844View SEC Filing Icon  
2/21/2023Blake BorgesonDirectorSell8,885$7.73$68,681.057,594,057View SEC Filing Icon  
2/21/2023Mubadala Investment Co PjscMajor ShareholderBuy94,418$7.74$730,795.3212,605,000View SEC Filing Icon  
2/16/2023Mubadala Investment Co PjscMajor ShareholderBuy42,682$7.90$337,187.8012,447,200View SEC Filing Icon  
2/15/2023Shafique ViraniInsiderSell7,486$8.33$62,358.38189,846View SEC Filing Icon  
2/14/2023Mubadala Investment Co PjscMajor ShareholderBuy6,300$7.95$50,085.0012,404,518View SEC Filing Icon  
2/10/2023Mubadala Investment Co PjscMajor ShareholderBuy11,000$7.98$87,780.0012,365,744View SEC Filing Icon  
2/7/2023Blake BorgesonDirectorSell8,885$8.81$78,276.857,602,942View SEC Filing Icon  
1/26/2023Tina Marriott LarsonCOOSell8,000$8.07$64,560.00203,654View SEC Filing Icon  
1/25/2023Mubadala Investment Co PjscMajor ShareholderBuy24,526$7.88$193,264.8812,346,258View SEC Filing Icon  
1/24/2023Blake BorgesonDirectorSell8,885$8.71$77,388.357,611,827View SEC Filing Icon  
1/17/2023Shafique ViraniInsiderSell10,000$9.16$91,600.0073,160View SEC Filing Icon  
1/10/2023Blake BorgesonDirectorSell8,885$7.69$68,325.657,620,712View SEC Filing Icon  
1/9/2023Mubadala Investment Co PjscMajor ShareholderBuy76,046$7.64$580,991.4412,252,214View SEC Filing Icon  
1/5/2023Christopher GibsonCEOSell18,500$7.39$136,715.00525,805View SEC Filing Icon  
1/5/2023Mubadala Investment Co PjscMajor ShareholderBuy80,035$7.38$590,658.3012,107,215View SEC Filing Icon  
1/3/2023Mubadala Investment Co PjscMajor ShareholderBuy141,646$7.50$1,062,345.0011,935,288View SEC Filing Icon  
12/29/2022Tina Marriott LarsonCOOSell8,000$7.70$61,600.00203,654View SEC Filing Icon  
12/27/2022Blake BorgesonDirectorSell8,885$7.25$64,416.257,628,272View SEC Filing Icon  
12/15/2022Shafique ViraniInsiderSell10,000$8.85$88,500.0078,160View SEC Filing Icon  
12/13/2022Blake BorgesonDirectorSell8,885$8.96$79,609.607,637,157View SEC Filing Icon  
12/1/2022Christopher GibsonCEOSell37,210$9.02$335,634.20582,805View SEC Filing Icon  
11/29/2022Blake BorgesonDirectorSell8,885$8.75$77,743.757,646,042View SEC Filing Icon  
11/17/2022Tina Marriott LarsonCOOSell16,000$10.96$175,360.00203,654View SEC Filing Icon  
11/16/2022Blake BorgesonDirectorSell17,770$11.12$197,602.407,654,927View SEC Filing Icon  
11/15/2022Shafique ViraniInsiderSell10,000$12.31$123,100.0083,160View SEC Filing Icon  
11/3/2022Christopher GibsonCEOSell36,693$10.00$366,930.00576,016View SEC Filing Icon  
10/27/2022Tina Marriott LarsonCOOSell16,000$10.72$171,520.00205,107View SEC Filing Icon  
10/14/2022Shafique ViraniInsiderSell10,000$10.92$109,200.0088,773View SEC Filing Icon  
10/6/2022Christopher GibsonCEOSell36,053$11.58$417,493.74562,959View SEC Filing Icon  
9/29/2022Tina Marriott LarsonCOOSell16,000$10.86$173,760.00205,107View SEC Filing Icon  
9/15/2022Shafique ViraniInsiderSell10,000$13.36$133,600.0093,773View SEC Filing Icon  
8/16/2022Shafique ViraniInsiderSell30,000$12.61$378,300.0098,773View SEC Filing Icon  
8/16/2022Tina Marriott LarsonCOOSell16,000$12.60$201,600.00295,107View SEC Filing Icon  
8/4/2022Christopher GibsonCEOSell36,825$9.49$349,469.25541,829View SEC Filing Icon  
7/7/2022Christopher GibsonCEOSell37,114$9.05$335,881.70528,904View SEC Filing Icon  
6/2/2022Christopher GibsonCEOSell39,690$6.09$241,712.10516,268View SEC Filing Icon  
5/4/2022Christopher GibsonCEOSell31,830$6.49$206,576.70511,972View SEC Filing Icon  
4/28/2022Christopher GibsonCEOSell37,605$6.09$229,014.45469,608View SEC Filing Icon  
4/21/2022Christopher GibsonCEOSell37,155$6.31$234,448.05420,146View SEC Filing Icon  
4/18/2022Christopher GibsonCEOSell35,836$6.84$245,118.24394,791View SEC Filing Icon  
4/14/2022Christopher GibsonCEOSell34,517$7.56$260,948.52368,117View SEC Filing Icon  
4/7/2022Christopher GibsonCEOSell36,718$6.54$240,135.72314,534View SEC Filing Icon  
4/5/2022Christopher GibsonCEOSell34,472$7.43$256,126.96288,742View SEC Filing Icon  
3/14/2022Christopher GibsonCEOSell230,000$6.28$1,444,400.00View SEC Filing Icon  
3/11/2022Christopher GibsonCEOSell100,000$6.95$695,000.00View SEC Filing Icon  
3/7/2022Christopher GibsonCEOSell300,000$7.30$2,190,000.00View SEC Filing Icon  
2/22/2022Christopher GibsonCEOSell100,000$10.22$1,022,000.00View SEC Filing Icon  
1/31/2022Christopher GibsonCEOSell19,858$11.73$232,934.34View SEC Filing Icon  
1/13/2022Christopher GibsonCEOSell87,000$14.33$1,246,710.00View SEC Filing Icon  
1/4/2022Blake BorgesonDirectorSell9,625$18.03$173,538.75View SEC Filing Icon  
12/21/2021Blake BorgesonDirectorSell9,625$18.75$180,468.75View SEC Filing Icon  
12/16/2021Christopher GibsonCEOSell200$20.00$4,000.00View SEC Filing Icon  
12/16/2021Tina Marriott LarsonCOOSell2,500$18.74$46,850.00View SEC Filing Icon  
12/13/2021Christopher GibsonCEOSell100$20.02$2,002.00View SEC Filing Icon  
12/9/2021Christopher GibsonCEOSell1,086$20.01$21,730.86View SEC Filing Icon  
12/7/2021Blake BorgesonDirectorSell9,625$20.32$195,580.00View SEC Filing Icon  
12/7/2021Christopher GibsonCEOSell3,125$20.51$64,093.75View SEC Filing Icon  
11/19/2021Dean Y. LiDirectorSell13,474$20.20$272,174.80View SEC Filing Icon  
11/18/2021Tina Marriott LarsonCOOSell2,500$18.92$47,300.00View SEC Filing Icon  
11/17/2021Dean Y. LiDirectorSell5,626$20.04$112,745.04View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Recursion Pharmaceuticals (NASDAQ:RXRX)

63.62% of Recursion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RXRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Recursion Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/22/2023Teachers Retirement System of The State of Kentucky174,435$1.35M0.0%+6.1%0.092%Search for SEC Filing on Google Icon
2/16/2023Alliancebernstein L.P.390,605$3.01M0.0%-87.9%0.206%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC27,093$0.21M0.0%-47.6%0.014%Search for SEC Filing on Google Icon
2/15/2023Lazard Asset Management LLC163,909$1.26M0.0%-46.1%0.086%Search for SEC Filing on Google Icon
2/15/2023State of Wisconsin Investment Board46,181$0.36M0.0%-36.3%0.024%Search for SEC Filing on Google Icon
2/15/2023Schonfeld Strategic Advisors LLC81,204$0.63M0.0%-30.6%0.043%Search for SEC Filing on Google Icon
2/15/2023Squarepoint Ops LLC69,800$0.54M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/15/2023Laurion Capital Management LP4,825,735$37.21M0.2%+5.2%2.546%Search for SEC Filing on Google Icon
2/15/2023Legal & General Group Plc93,970$0.73M0.0%+5.0%0.050%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC695,373$5.36M0.0%+190.5%0.367%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley333,171$2.57M0.0%+20.7%0.176%Search for SEC Filing on Google Icon
2/15/2023Norges Bank4,371,313$33.70M0.0%N/A2.306%Search for SEC Filing on Google Icon
2/15/2023E Fund Management Co. Ltd.27,111$0.21M0.0%+128.6%0.014%Search for SEC Filing on Google Icon
2/15/2023Alps Advisors Inc.123,165$0.95M0.0%+36.6%0.065%Search for SEC Filing on Google Icon
2/14/2023Vident Investment Advisory LLC13,581$0.11M0.0%+16.6%0.007%Search for SEC Filing on Google Icon
2/14/2023Price T Rowe Associates Inc. MD75,919$0.59M0.0%+109.7%0.040%Search for SEC Filing on Google Icon
2/14/2023Amundi7,189$57K0.0%+69.6%0.004%Search for SEC Filing on Google Icon
2/14/2023Alpine Global Management LLC15,533$0.12M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/14/2023Two Sigma Investments LP73,103$0.56M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/13/2023Platinum Investment Management Ltd.2,710,339$20.90M0.8%+20.4%1.430%Search for SEC Filing on Google Icon
2/13/2023Charles Schwab Investment Management Inc.984,681$7.59M0.0%+8.9%0.519%Search for SEC Filing on Google Icon
2/13/2023Deutsche Bank AG70,973$0.55M0.0%+22.2%0.037%Search for SEC Filing on Google Icon
2/13/2023Nikko Asset Management Americas Inc.454,522$3.50M0.1%-7.4%0.240%Search for SEC Filing on Google Icon
2/13/2023Barclays PLC296,600$2.29M0.0%+164.3%0.156%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC193,900$1.50M0.0%+1,175.7%0.102%Search for SEC Filing on Google Icon
2/13/2023The Manufacturers Life Insurance Company 55,778$0.43M0.0%+2.7%0.029%Search for SEC Filing on Google Icon
2/13/2023Credit Suisse AG1,575,590$12.15M0.0%+0.7%0.831%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC2,609,948$20.12M0.0%+11.9%1.377%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP22,603$0.17M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/13/2023JPMorgan Chase & Co.173,336$1.34M0.0%-4.3%0.091%Search for SEC Filing on Google Icon
2/13/2023Artal Group S.A.960,204$7.40M0.4%+113.4%0.507%Search for SEC Filing on Google Icon
2/10/2023Bank of America Corp DE421,864$3.25M0.0%+112.1%0.223%Search for SEC Filing on Google Icon
2/10/2023Schroder Investment Management Group159,964$1.23M0.0%+47.0%0.084%Search for SEC Filing on Google Icon
2/10/2023Connor Clark & Lunn Investment Management Ltd.144,013$1.11M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/10/2023Aigen Investment Management LP20,250$0.16M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/9/2023Hamilton Lane Advisors LLC96,474$0.74M0.3%+72.7%0.051%Search for SEC Filing on Google Icon
2/9/2023First Trust Advisors LP241,147$1.86M0.0%+86.3%0.127%Search for SEC Filing on Google Icon
2/9/2023Dimensional Fund Advisors LP189,928$1.46M0.0%N/A0.100%Search for SEC Filing on Google Icon
2/9/2023Principal Financial Group Inc.34,483$0.27M0.0%+4.9%0.018%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.232,827$1.80M0.0%+44.1%0.123%Search for SEC Filing on Google Icon
2/8/2023UBS Group AG361,895$2.79M0.0%+1,859.9%0.191%Search for SEC Filing on Google Icon
2/8/2023Swiss National Bank119,600$0.92M0.0%+2.7%0.063%Search for SEC Filing on Google Icon
2/8/2023Russell Investments Group Ltd.131,956$1.02M0.0%-2.3%0.070%Search for SEC Filing on Google Icon
2/8/2023Dakota Wealth Management13,438$0.10M0.0%-50.0%0.007%Search for SEC Filing on Google Icon
2/7/2023LPL Financial LLC45,860$0.35M0.0%+9.8%0.024%Search for SEC Filing on Google Icon
2/7/2023Handelsbanken Fonder AB18,800$0.15M0.0%+41.4%0.010%Search for SEC Filing on Google Icon
2/7/2023Mitsubishi UFJ Kokusai Asset Management Co. Ltd.18,733$0.14M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/6/2023Daiwa Securities Group Inc.6,903$53K0.0%+1,029.8%0.004%Search for SEC Filing on Google Icon
2/6/2023Jackson Creek Investment Advisors LLC77,011$0.59M0.3%N/A0.041%Search for SEC Filing on Google Icon
2/2/2023SG Americas Securities LLC28,022$0.22M0.0%+54.5%0.015%Search for SEC Filing on Google Icon
2/2/2023ProShare Advisors LLC32,611$0.25M0.0%+12.8%0.017%Search for SEC Filing on Google Icon
2/1/2023Zurcher Kantonalbank Zurich Cantonalbank 18,954$0.15M0.0%+26.7%0.010%Search for SEC Filing on Google Icon
2/1/2023Kinnevik AB publ 7,653,061$59.01M33.3%N/A4.037%Search for SEC Filing on Google Icon
2/1/2023Cypress Point Wealth Management LLC14,219$0.11M0.2%+40.0%0.008%Search for SEC Filing on Google Icon
1/30/2023Sumitomo Mitsui Trust Holdings Inc.454,522$3.50M0.0%-7.4%0.240%Search for SEC Filing on Google Icon
1/24/2023ARK Investment Management LLC3,099,490$23.90M0.2%-7.7%1.635%Search for SEC Filing on Google Icon
1/24/2023Baillie Gifford & Co.24,820,850$191.37M0.2%+14.9%12.980%Search for SEC Filing on Google Icon
1/11/2023Foundations Investment Advisors LLC16,656$0.13M0.0%-23.3%0.009%Search for SEC Filing on Google Icon
12/8/2022Bank of New York Mellon Corp503,941$5.36M0.0%+26.2%0.266%Search for SEC Filing on Google Icon
11/22/2022Teachers Retirement System of The State of Kentucky164,435$1.75M0.0%N/A0.087%Search for SEC Filing on Google Icon
11/21/2022California State Teachers Retirement System96,266$1.02M0.0%-2.3%0.051%Search for SEC Filing on Google Icon
11/16/2022Advisory Research Inc.96,803$1.03M0.1%+56.6%0.056%Search for SEC Filing on Google Icon
11/16/2022BNP Paribas Arbitrage SNC107,034$1.14M0.0%N/A0.062%Search for SEC Filing on Google Icon
11/15/2022Alliancebernstein L.P.3,237,344$34.45M0.0%-10.1%1.870%Search for SEC Filing on Google Icon
11/15/2022State Street Corp4,555,759$48.47M0.0%+114.3%2.632%Search for SEC Filing on Google Icon
11/15/2022Trexquant Investment LP11,800$0.13M0.0%-78.3%0.007%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Ventures LP903,400$9.61M100.0%-50.0%0.522%Search for SEC Filing on Google Icon
11/15/2022UBS Asset Management Americas Inc.76,879$0.82M0.0%+49.4%0.044%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.8,380,986$89.17M0.0%+19.9%4.842%Search for SEC Filing on Google Icon
11/15/2022Platinum Investment Management Ltd.2,251,971$23.96M1.0%-11.2%1.301%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD36,206$0.39M0.0%+58.8%0.021%Search for SEC Filing on Google Icon
11/15/2022Quantamental Technologies LLC11,981$0.13M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/15/2022Martingale Asset Management L P25,200$0.27M0.0%+127.0%0.015%Search for SEC Filing on Google Icon
11/15/2022First Trust Advisors LP129,438$1.38M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp503,941$5.36M0.0%+26.2%0.291%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.9,767,040$103.92M0.0%+18.5%5.643%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC111,575$1.19M0.0%+376.7%0.064%Search for SEC Filing on Google Icon
11/14/2022Bienville Capital Management LLC60,938$0.65M0.3%+66.7%0.035%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC15,200$0.16M0.0%-94.2%0.009%Search for SEC Filing on Google Icon
11/14/2022Lazard Asset Management LLC304,212$3.24M0.0%+5.0%0.176%Search for SEC Filing on Google Icon
11/14/2022Nuveen Asset Management LLC847,137$9.01M0.0%+49.0%0.489%Search for SEC Filing on Google Icon
11/14/2022Crown Advisors Management Inc.30,000$0.32M0.3%N/A0.017%Search for SEC Filing on Google Icon
11/14/2022Hsbc Holdings PLC10,201$0.11M0.0%-22.0%0.006%Search for SEC Filing on Google Icon
11/14/2022E Fund Management Co. Ltd.11,859$0.13M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/10/2022Dakota Wealth Management26,901$0.29M0.0%N/A0.016%Search for SEC Filing on Google Icon
11/10/2022ExodusPoint Capital Management LP45,832$0.49M0.0%-76.1%0.026%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC15,411$0.16M0.0%+223.6%0.009%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG18,465$0.20M0.0%+270.3%0.011%Search for SEC Filing on Google Icon
11/10/2022Mitsubishi UFJ Trust & Banking Corp367,390$3.91M0.0%-1.6%0.212%Search for SEC Filing on Google Icon
11/9/2022Massachusetts Financial Services Co. MA950,594$10.11M0.0%-28.4%0.549%Search for SEC Filing on Google Icon
11/8/2022Hamilton Lane Advisors LLC55,850$0.59M0.2%+266.8%0.032%Search for SEC Filing on Google Icon
11/8/2022Manchester Capital Management LLC26,880$0.29M0.0%+100.0%0.016%Search for SEC Filing on Google Icon
11/7/2022Nisa Investment Advisors LLC50,384$0.54M0.0%-34.9%0.029%Search for SEC Filing on Google Icon
11/4/2022Russell Investments Group Ltd.135,073$1.44M0.0%+5.1%0.079%Search for SEC Filing on Google Icon
11/4/2022Ieq Capital LLC17,920$0.19M0.0%N/A0.010%Search for SEC Filing on Google Icon
11/3/2022Teacher Retirement System of Texas16,043$0.17M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/3/2022The Manufacturers Life Insurance Company54,320$0.58M0.0%-1.9%0.032%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC112,234$1.20M0.0%+448.2%0.066%Search for SEC Filing on Google Icon
11/2/2022Rockefeller Capital Management L.P.7,319$77K0.0%+23.2%0.004%Search for SEC Filing on Google Icon
11/2/2022DekaBank Deutsche Girozentrale60,000$0.65M0.0%+55.8%0.035%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Recursion Pharmaceuticals logo
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Read More on Recursion Pharmaceuticals

Today's Range

Now: $6.98
Low: $6.95
High: $7.47

50 Day Range

MA: $8.17
Low: $6.98
High: $9.64

52 Week Range

Now: $6.98
Low: $4.92
High: $14.18

Volume

862,731 shs

Average Volume

961,801 shs

Market Capitalization

$1.33 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Recursion Pharmaceuticals?

Recursion Pharmaceuticals' top insider investors include:
  1. Mubadala Investment Co Pjsc (Major Shareholder)
  2. Blake Borgeson (Director)
  3. Christopher Gibson (CEO)
  4. Tina Marriott Larson (COO)
  5. Shafique Virani (Insider)
  6. Dean Y Li (Director)
Learn More about top insider investors at Recursion Pharmaceuticals.

Who are the major institutional investors of Recursion Pharmaceuticals?

Recursion Pharmaceuticals' top institutional investors include:
  1. Baillie Gifford & Co. — 12.98%
  2. Kinnevik AB publ — 4.04%
  3. Laurion Capital Management LP — 2.55%
  4. Norges Bank — 2.31%
  5. ARK Investment Management LLC — 1.64%
  6. Platinum Investment Management Ltd. — 1.43%
Learn More about top institutional investors of Recursion Pharmaceuticals stock.

Which institutional investors are selling Recursion Pharmaceuticals stock?

Within the previous quarter, RXRX stock was sold by these institutional investors:
  1. Alliancebernstein L.P.
  2. ARK Investment Management LLC
  3. Lazard Asset Management LLC
  4. Sumitomo Mitsui Trust Holdings Inc.
  5. Nikko Asset Management Americas Inc.
  6. Schonfeld Strategic Advisors LLC
  7. State of Wisconsin Investment Board
  8. Jane Street Group LLC
During the last year, company insiders that have sold Recursion Pharmaceuticals company stock include:
  1. Mubadala Investment Co Pjsc (Major Shareholder)
  2. Blake Borgeson (Director)
  3. Christopher Gibson (CEO)
  4. Tina Marriott Larson (COO)
Learn More investors selling Recursion Pharmaceuticals stock.

Which institutional investors are buying Recursion Pharmaceuticals stock?

In the previous quarter, RXRX stock was purchased by institutional investors including:
  1. Kinnevik AB publ
  2. Norges Bank
  3. Baillie Gifford & Co.
  4. Artal Group S.A.
  5. Platinum Investment Management Ltd.
  6. Millennium Management LLC
  7. UBS Group AG
  8. Geode Capital Management LLC